CMIC Group headquarters office is located in Tokyo, Japan.

CMIC was founded in 1992 as the first Contract Research Organization (CRO) in Japan. To enable pharmaceutical companies to develop better medicine sooner, we expanded our solutions to include drug development and manufacturing, site management, sales and marketing, and established an innovative pharma model to bring highly desired treatments to the Japanese market. We offer various solutions based on our unique Pharmaceutical Value Creator (PVC) model.


  • Contract Research Organization (CRO) services
  • Contract Development and Manufacturing Organization (CDMO) services
  • Site Management Organization (SMO) services
  • Contract Sales Organization (CSO) services
  • Healthcare services
  • Innovative Pharma Model / Japan Market Entry services

Facility Accreditations/Credentials

  • First-class marketing license for pharmaceuticals
  • Second-class marketing license for pharmaceuticals
  • Marketing license for in-vitro diagnostics
  • Marketing license for quasi-drugs
  • Marketing license for selling pharmaceuticals cosmetics
  • First-class marketing license for medical devices
  • Licenses for Selling Specially-Controlled Medical Devices
  • Licenses for Leasing Operations for Specially-Controlled Medical Devices

Facility Contact Information

Hamamatsucho Bldg., 1-1-1 Shibaura, Minato-ku
Tokyo, Japan 105-0023

Phone: +81-3-6779-8000

Business Inquires

Contract Research Organization

Contract Research Organization (CRO)

Drug Manufacturing

Contract Development & Manufacturing Organization (CDMO)

Patient support

Site Management Organization (SMO)

Contract Sales Organization with Globe

Contract Sales Organization (CSO)

Patient and Health Services

Patient & Healthcare Services

IPM Japan

Innovative Pharma Model (IPM)

Orphan Drug

Orphan Drug: OrphanPacific Website